Prolonged infusion of dexmedetomidine for sedation following tracheal resection
| Autor: | Alan R. Schroeder, Frederick S. Rosen, Peter J. Koltai, Bridget M. Philip, Gregory B. Hammer |
|---|---|
| Rok vydání: | 2005 |
| Předmět: |
Male
Drug Agonist medicine.medical_specialty medicine.drug_class Subglottic stenosis media_common.quotation_subject Sedation medicine.medical_treatment Conscious Sedation Tracheal resection Humans Hypnotics and Sedatives Medicine Anesthesia Adrenergic agonist Dexmedetomidine Child Infusions Intravenous media_common Mechanical ventilation Laryngoscopy business.industry medicine.disease Respiration Artificial Surgery Trachea Anesthesiology and Pain Medicine Pediatrics Perinatology and Child Health medicine.symptom Tracheal Stenosis business medicine.drug |
| Zdroj: | Pediatric Anesthesia. 15:616-620 |
| ISSN: | 1460-9592 1155-5645 |
| DOI: | 10.1111/j.1460-9592.2005.01656.x |
| Popis: | Summary Dexmedetomidine is a centrally acting alpha-2 adrenergic agonist that is currently approved by the US Food and Drug Administration for short-term use (≤24 h) to provide sedation in adults in the ICU. This drug has been shown to be efficacious in adult medical and surgical patients in providing sedation, anxiolysis, and analgesia. Dexmedetomidine has been associated with rapid onset and offset, hemodynamic stability, and a natural, sleep-like state in mechanically ventilated adults. To date, there are few publications of the use of this drug in children, and prolonged infusion has not been described. We report our use of dexmedetomidine in a child during a 4-day period of mechanical ventilation following tracheal reconstruction for subglottic stenosis. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|